TGTX in the 13F filings
TG Therapeutics Inc · CUSIP 88322Q108
- Quarter end
- 31 Mar 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 May 2026
- Managers listing it
- 28
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q4 2025 and Q1 2026; 3 listed it in both
- Shares listed
- 11,480,823
- combined, among listed positions
- Reported value
- $381m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 14 buyers (opened or added shares) and 17 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -273,135.
Managers listing TGTX in Q1 2026
28 of 28 holders
Largest increases and reductions, by shares
Increases
- Jane Street Group LLCexisting position · 2,041,669 shares now+1,071,694
- Citadel Advisors LLCexisting position · 1,922,889 shares now+911,852
- Woodline Partners LPnew position · 715,500 shares now+715,500
- Two Sigma Investments LPexisting position · 1,542,312 shares now+481,864
- Renaissance Technologies LLCnew position · 340,900 shares now+340,900
Reductions
- Invesco Ltdexisting position · 720,934 shares now-888,881
- Man Group PLCexisting position · 354,697 shares now-601,940
- Millennium Management LLCexisting position · 122,587 shares now-553,323
- Susquehanna International Group LLPexisting position · 544,720 shares now-342,731
- Squarepoint Ops LLCexisting position · 513,813 shares now-338,709
New positions and exits
New (4)
Exited (5)
- Voloridge Investment Management LLCwas $17m
- Point72 Asset Management LPwas $6.9m
- ExodusPoint Capital Management LPwas $4.8m
- Tudor Investment Corpwas $2.9m
- Schonfeld Strategic Advisors LLCwas $638k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2018 | 2 | $9.0m | n.a. | n.a. |
| Q1 2019 | 2 | $50m | n.a. | n.a. |
| Q2 2019 | 2 | $52m | n.a. | n.a. |
| Q3 2019 | 1 | $42m | n.a. | n.a. |
| Q1 2020 | 1 | $162k | n.a. | n.a. |
| Q2 2020 | 4 | $47m | n.a. | n.a. |
| Q3 2020 | 3 | $416m | n.a. | n.a. |
| Q4 2020 | 7 | $1.3bn | n.a. | n.a. |
| Q1 2021 | 6 | $1.4bn | n.a. | n.a. |
| Q2 2021 | 6 | $1.2bn | n.a. | n.a. |
| Q3 2021 | 4 | $893m | n.a. | n.a. |
| Q4 2021 | 2 | $194m | n.a. | n.a. |
| Q1 2022 | 2 | $74m | n.a. | n.a. |
| Q2 2022 | 2 | $29m | n.a. | n.a. |
| Q3 2022 | 2 | $51m | n.a. | n.a. |
| Q4 2022 | 5 | $108m | n.a. | n.a. |
| Q1 2023 | 3 | $55m | n.a. | n.a. |
| Q2 2023 | 7 | $154m | n.a. | n.a. |
| Q3 2023 | 5 | $47m | n.a. | n.a. |
| Q4 2023 | 2 | $36m | 1 | 2 |
| Q1 2024 | 3 | $37m | 2 | 1 |
| Q2 2024 | 6 | $109m | 6 | 0 |
| Q3 2024 | 6 | $94m | 4 | 3 |
| Q4 2024 | 3 | $2.7m | 0 | 3 |
| Q1 2025 | 5 | $57m | 3 | 1 |
| Q2 2025 | 4 | $49m | 3 | 1 |
| Q3 2025 | 6 | $102m | 5 | 1 |
| Q4 2025 | 6 | $83m | 23 | 8 |
| Q1 2026 | 5 | $88m | 14 | 17 |
| Q2 2026 | 8 | $445m | 21 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TGTX and LLY →TGTX and JNJ →TGTX and VRTX →Choose a stock to compare with TGTX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TGTX, latest filings →Back to the 13F Explorer →